Expertise in
5
conditions

Dr. Francisco M. Marty

Infectious Disease
Brigham And Women's Hospital
75 Francis St, 
Boston, MA 
Expertise in
5
conditions
Brigham And Women's Hospital
75 Francis St, 
Boston, MA 

Overview

Francisco Marty is an Infectious Disease provider practicing medicine in Boston, Massachusetts.

Dr. Marty is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Cytomegalovirus Infection, Cytomegalic Inclusion Disease, Sepsis, and Febrile Neutropenia.

He is actively involved in clinical research, co-authoring 161 peer reviewed articles and participating in 9 clinical trials.

Specialties

Infectious Disease

Licenses

Internal Medicine in MA

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO

Locations

Brigham and Women's Hospital
75 Francis St, Boston, MA 02115

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

Phase IIb Study of F901318 as Treatment of Invasive Fungal Infections Due to Lomentospora Prolificans, Scedosporium Spp., Aspergillus Spp., and Other Resistant Fungi in Patients Lacking Suitable Alternative Treatment Options
Phase IIb Study of F901318 as Treatment of Invasive Fungal Infections Due to Lomentospora Prolificans, Scedosporium Spp., Aspergillus Spp., and Other Resistant Fungi in Patients Lacking Suitable Alternative Treatment Options
Enrollment Status: Completed
Publish Date: July 10, 2024
Intervention Type: Drug
Study Phase: Phase 2
Prospective Study of BK Virus Disease After Allogeneic Hematopoietic-cell Transplantation: Defining BK Disease's Natural History, Clinical Spectrum, Immunology, and Outcomes
Prospective Study of BK Virus Disease After Allogeneic Hematopoietic-cell Transplantation: Defining BK Disease's Natural History, Clinical Spectrum, Immunology, and Outcomes
Enrollment Status: Completed
Publish Date: May 22, 2024
Intervention Type: Diagnostic test, Other
A Phase 2 Study of Letermovir Treatment for Patients Experiencing Refractory or Resistant Cytomegalovirus Infection or Disease With Concurrent Organ Dysfunction
A Phase 2 Study of Letermovir Treatment for Patients Experiencing Refractory or Resistant Cytomegalovirus Infection or Disease With Concurrent Organ Dysfunction
Enrollment Status: Completed
Publish Date: March 08, 2023
Intervention Type: Drug
Study Drug: Letermovir
Study Phase: Phase 2
A Phase 3, Multicenter, Randomized, Double-blind, Double-dummy, Active-controlled Study to Assess the Efficacy and Safety of Maribavir Compared to Valganciclovir for the Treatment of Cytomegalovirus (CMV) Infection in Hematopoietic Stem Cell Transplant Recipients
A Phase 3, Multicenter, Randomized, Double-blind, Double-dummy, Active-controlled Study to Assess the Efficacy and Safety of Maribavir Compared to Valganciclovir for the Treatment of Cytomegalovirus (CMV) Infection in Hematopoietic Stem Cell Transplant Recipients
Enrollment Status: Completed
Publish Date: March 03, 2023
Intervention Type: Drug, Other
Study Phase: Phase 3
An Intermediate-size, Expanded Access Protocol to Provide Brincidofovir for the Treatment of Serious Adenovirus Infection or Disease
An Intermediate-size, Expanded Access Protocol to Provide Brincidofovir for the Treatment of Serious Adenovirus Infection or Disease
Enrollment Status: No_longer_available
Publish Date: March 14, 2022
Intervention Type: Drug
A Phase 3, Multicenter, Randomized, Open-label, Active-controlled Study to Assess the Efficacy and Safety of Maribavir Treatment Compared to Investigator-assigned Treatment in Transplant Recipients With Cytomegalovirus (CMV) Infections That Are Refractory or Resistant to Treatment With Ganciclovir, Valganciclovir, Foscarnet, or Cidofovir
A Phase 3, Multicenter, Randomized, Open-label, Active-controlled Study to Assess the Efficacy and Safety of Maribavir Treatment Compared to Investigator-assigned Treatment in Transplant Recipients With Cytomegalovirus (CMV) Infections That Are Refractory or Resistant to Treatment With Ganciclovir, Valganciclovir, Foscarnet, or Cidofovir
Enrollment Status: Completed
Publish Date: November 03, 2021
Intervention Type: Drug
Study Phase: Phase 3
A Prospective Observational Study for the Long-term Follow-up of Subjects Previously Enrolled in Selected Clinical Studies of CMX001.
A Prospective Observational Study for the Long-term Follow-up of Subjects Previously Enrolled in Selected Clinical Studies of CMX001.
Enrollment Status: Terminated
Publish Date: May 17, 2019
Intervention Type: Drug
View 6 Less Clinical Trials

161 Total Publications

Effectiveness of Casirivimab and Imdevimab Antibody Combination in Immunocompromised Hospitalized Patients With Coronavirus Disease 2019: A Post Hoc Analysis in a Phase 1/2/3 Double-Blind Trial.
Effectiveness of Casirivimab and Imdevimab Antibody Combination in Immunocompromised Hospitalized Patients With Coronavirus Disease 2019: A Post Hoc Analysis in a Phase 1/2/3 Double-Blind Trial.
Journal: Open forum infectious diseases
Published: January 26, 2023
Similar Doctors
Expertise in
9
conditions
Dr. Kenneth H. Mayer
Infectious Disease
Expertise in
9
conditions
Dr. Kenneth H. Mayer
Infectious Disease
Referral may be required

Fenway Community Health Center Inc.

1340 Boylston St, 
Boston, MA 
 (0.7 miles away)
617-927-6087
Languages Spoken:
English
See accepted insurances

Kenneth Mayer is an Infectious Disease provider practicing medicine in Boston, Massachusetts. Dr. Mayer is highly rated in 9 conditions, according to our data. His clinical expertise encompasses HIV/AIDS, Syphilis, Gonorrhea, Chlamydia, and Tissue Biopsy.

Expertise in
6
conditions
Dr. Michael Klompas
Infectious Disease
Expertise in
6
conditions
Dr. Michael Klompas
Infectious Disease
Referral may be required

Office

15 Francis St # 4, 
Boston, MA 
 (0.1 miles away)
617-732-8881
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Michael Klompas is an Infectious Disease provider practicing medicine in Boston, Massachusetts. Dr. Klompas is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Hospital-Acquired Pneumonia, Pneumonia, Sepsis, and Severe Acute Respiratory Syndrome (SARS). Dr. Klompas is currently accepting new patients.

Expertise in
16
conditions
Dr. Davidson H. Hamer
Infectious Disease
Expertise in
16
conditions
Dr. Davidson H. Hamer
Infectious Disease
Referral may be required

Boston Medical Center

1 Boston Medical Ctr Pl, 
Boston, MA 
 (1.7 miles away)
857-654-1000
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients

Davidson Hamer is an Infectious Disease provider practicing medicine in Boston, Massachusetts. Dr. Hamer is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Chagas Disease, Yellow Fever, Viral Hemorrhagic Fever, and Togaviridae Disease. Dr. Hamer is currently accepting new patients.

Frequently Asked Questions about Dr. Francisco M. Marty

How do I make an appointment with Dr. Francisco M. Marty?

You can book an appointment with Dr. Francisco M. Marty by calling their office at 617-732-8881. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Francisco M. Marty a top-rated expert for Cytomegalovirus Infection?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Francisco M. Marty is classified as an Elite expert for Cytomegalovirus Infection, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Francisco M. Marty specialize in?

While Dr. Francisco M. Marty is a Infectious Disease, they have specific expertise in Cytomegalovirus Infection, Cytomegalic Inclusion Disease, and Sepsis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Infectious Disease.

Does Dr. Francisco M. Marty participate in research or clinical trials?

Yes. Dr. Francisco M. Marty has published 161 articles and abstracts on conditions like Cytomegalovirus Infection. You can view a list of Dr. Francisco M. Marty's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Francisco M. Marty accept my insurance?

Dr. Francisco M. Marty accepts most major insurance plans, including Humana. We recommend calling the office directly at 617-732-8881 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Marty's expertise for a condition
ConditionClose
View All 25 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile